By contrast, blockade of AMPK by Compound C or shRNA, as well as activation of mTOR by the specific activator MHY1485, significantly reversed the inhibitory effects of FATP5 on cancer cell metastasis. The gene discussed is PRKAA1; the disease is cancer.